| NCT04187144 |
Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI) |
https://ClinicalTrials.gov/show/NCT04187144 |
Recruiting |
GlaxoSmithKline |
2021-12-20 |
| NCT03408392 |
Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions |
https://ClinicalTrials.gov/show/NCT03408392 |
Completed |
GlaxoSmithKline |
2018-03-13 |
| NCT03369951 |
Minocycline Pharmacokinetics (ACUMIN) |
https://ClinicalTrials.gov/show/NCT03369951 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2019-07-20 |
| NCT03361163 |
Controlled Human Infection for Vaccination Against Streptococcus Pyogenes |
https://ClinicalTrials.gov/show/NCT03361163 |
Completed |
Murdoch Childrens Research Institute |
2019-09-28 |
| NCT03299894 |
Impact of qSOFA Calculation on the Timing of Antimicrobial Therapy in the Emergency Department |
https://ClinicalTrials.gov/show/NCT03299894 |
Completed |
Centre Hospitalier Régional d’Orléans |
2018-06-10 |
| NCT03244917 |
Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer’s Disease and Other Dementias |
https://ClinicalTrials.gov/show/NCT03244917 |
Recruiting |
Hebrew Rehabilitation Center, Boston |
2020-08-31 |
| NCT03234738 |
A Phase 1 Safety and PK Study of IV TP-271 |
https://ClinicalTrials.gov/show/NCT03234738 |
Active, not recruiting |
Tetraphase Pharmaceuticals, Inc. |
2018-10-31 |
| NCT03233438 |
Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) |
https://ClinicalTrials.gov/show/NCT03233438 |
Completed |
Allergan |
2018-10-30 |
| NCT03230916 |
A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020) |
https://ClinicalTrials.gov/show/NCT03230916 |
Recruiting |
Merck Sharp & Dohme Corp. |
2020-08-13 |
| NCT03182504 |
A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants |
https://ClinicalTrials.gov/show/NCT03182504 |
Completed |
Hoffmann-La Roche |
2017-08-10 |
| NCT03163628 |
biomArkers to differeNtiate bacTerial From vIral iNfEctions |
https://ClinicalTrials.gov/show/NCT03163628 |
Completed |
Hospices Civils de Lyon |
2019-06-12 |
| NCT03150082 |
Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT03150082 |
Completed |
GlaxoSmithKline |
2017-08-28 |
| NCT03133312 |
Chlorhexidine Gluconate Versus Povidone-Iodine as Vaginal Preparation Antiseptics Prior to Cesarean Delivery |
https://ClinicalTrials.gov/show/NCT03133312 |
Completed |
Metro Health, Michigan |
2017-12-30 |
| NCT03124199 |
Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection |
https://ClinicalTrials.gov/show/NCT03124199 |
Completed |
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa |
2015-03-31 |
| NCT03079609 |
The Search for Viral and Bacterial Etiology of Varicocele |
https://ClinicalTrials.gov/show/NCT03079609 |
Active, not recruiting |
Medical University of Warsaw |
2019-12-31 |
| NCT03009734 |
Evaluation of ATx201 as a Topical Antibiotic Agent |
https://ClinicalTrials.gov/show/NCT03009734 |
Completed |
UNION therapeutics |
2018-03-31 |
| NCT02992951 |
DACC in the REduction of Surgical Site INfection |
https://ClinicalTrials.gov/show/NCT02992951 |
Completed |
Hull University Teaching Hospitals NHS Trust |
2018-08-01 |
| NCT02988349 |
Ecological Effect of Arginine Dentifrice on Oral Microbiota |
https://ClinicalTrials.gov/show/NCT02988349 |
Completed |
Sichuan University |
2014-07-31 |
| NCT02955459 |
VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT02955459 |
Completed |
VenatoRx Pharmaceuticals, Inc. |
2017-06-30 |
| NCT02914132 |
Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis |
https://ClinicalTrials.gov/show/NCT02914132 |
Completed |
ExThera Medical Corporation |
2018-06-07 |
| NCT02882568 |
Analysis of Immune Response In Bacterial Infection of Obese Subject |
https://ClinicalTrials.gov/show/NCT02882568 |
Completed |
Versailles Hospital |
2016-02-29 |
| NCT02877927 |
Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI |
https://ClinicalTrials.gov/show/NCT02877927 |
Completed |
Paratek Pharmaceuticals Inc |
2017-05-26 |
| NCT02858700 |
Value for Cord Blood Procalcitonin to Diagnose Early Neonatal Bacterial Infection |
https://ClinicalTrials.gov/show/NCT02858700 |
Completed |
University Hospital, Montpellier |
2015-12-31 |
| NCT02853435 |
To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects. |
https://ClinicalTrials.gov/show/NCT02853435 |
Completed |
GlaxoSmithKline |
2017-10-17 |
| NCT02814916 |
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA |
https://ClinicalTrials.gov/show/NCT02814916 |
Recruiting |
Allergan |
2021-12-31 |
| NCT02754765 |
Evaluating Newly Approved Drugs for Multidrug-resistant TB |
https://ClinicalTrials.gov/show/NCT02754765 |
Recruiting |
Médecins Sans Frontières, France |
2020-09-30 |
| NCT02753387 |
Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT02753387 |
Completed |
Rennes University Hospital |
2018-09-05 |
| NCT02750761 |
A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013) |
https://ClinicalTrials.gov/show/NCT02750761 |
Completed |
Merck Sharp & Dohme Corp. |
2018-12-16 |
| NCT02729038 |
Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function |
https://ClinicalTrials.gov/show/NCT02729038 |
Completed |
GlaxoSmithKline |
2017-06-20 |
| NCT02690181 |
Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects. |
https://ClinicalTrials.gov/show/NCT02690181 |
Completed |
GlaxoSmithKline |
2016-11-02 |
| NCT02687906 |
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections |
https://ClinicalTrials.gov/show/NCT02687906 |
Recruiting |
Melinta Therapeutics, Inc. |
2021-08-31 |
| NCT02655302 |
Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD |
https://ClinicalTrials.gov/show/NCT02655302 |
Recruiting |
University Hospital, Lille |
2025-07-31 |
| NCT02598141 |
Grinding Versus Standard Methods for the Treatment of Per-operative Bacteriological Samples Associated With Osteo-articular Sepsis |
https://ClinicalTrials.gov/show/NCT02598141 |
Recruiting |
Centre Hospitalier Universitaire de NÄ«mes |
2018-11-30 |
| NCT02436876 |
Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites |
https://ClinicalTrials.gov/show/NCT02436876 |
Completed |
Microbion Corporation |
2018-07-26 |
| NCT03978091 |
A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam |
https://ClinicalTrials.gov/show/NCT03978091 |
Recruiting |
National Institute of Allergy and Infectious Diseases (NIAID) |
2020-11-04 |
| NCT03568942 |
Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis) |
https://ClinicalTrials.gov/show/NCT03568942 |
Completed |
GlaxoSmithKline |
2019-01-07 |
| NCT03397433 |
ANti-infective Stewardship Using the Wisca Tool in the Electronic Medical Record |
https://ClinicalTrials.gov/show/NCT03397433 |
Completed |
NorthShore University HealthSystem |
2018-07-31 |
| NCT02553083 |
High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection |
https://ClinicalTrials.gov/show/NCT02553083 |
Recruiting |
Rabin Medical Center |
2020-09-30 |
| NCT02543827 |
Evaluation of the Efficacy and Safety of MV140 |
https://ClinicalTrials.gov/show/NCT02543827 |
Active, not recruiting |
Inmunotek S.L. |
2020-12-31 |
| NCT02541695 |
Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli |
https://ClinicalTrials.gov/show/NCT02541695 |
Completed |
NIZO Food Research |
2016-03-31 |
| NCT02527681 |
Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics |
https://ClinicalTrials.gov/show/NCT02527681 |
Recruiting |
Basilea Pharmaceutica |
2020-12-31 |
| NCT02500654 |
Regenerative Surgical Treatment of Peri-implantitis |
https://ClinicalTrials.gov/show/NCT02500654 |
Completed |
Region Gävleborg |
2014-01-31 |
| NCT02475876 |
PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children |
https://ClinicalTrials.gov/show/NCT02475876 |
Active, not recruiting |
Duke University |
2018-08-31 |
| NCT02452047 |
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013) |
https://ClinicalTrials.gov/show/NCT02452047 |
Completed |
Merck Sharp & Dohme Corp. |
2017-09-18 |
| NCT02378480 |
Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23) |
https://ClinicalTrials.gov/show/NCT02378480 |
Completed |
Paratek Pharmaceuticals Inc |
2016-04-30 |
| NCT02375477 |
Improved Adherence to C. Difficile Isolation Protocols Through Improved Education Methods |
https://ClinicalTrials.gov/show/NCT02375477 |
Completed |
Case Comprehensive Cancer Center |
2016-01-06 |
| NCT02361866 |
To Evaluate the Effectiveness(Immunogeneicity) and Safety of ‘GC1107’ Administered Intramuscularly in Healthy Adults |
https://ClinicalTrials.gov/show/NCT02361866 |
Completed |
Green Cross Corporation |
2014-09-30 |
| NCT02339155 |
Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed |
https://ClinicalTrials.gov/show/NCT02339155 |
Completed |
Emergent BioSolutions |
2017-01-03 |
| NCT02306330 |
MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial |
https://ClinicalTrials.gov/show/NCT02306330 |
Completed |
Oxford University Clinical Research Unit, Vietnam |
2016-01-31 |
| NCT02294175 |
Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm |
https://ClinicalTrials.gov/show/NCT02294175 |
Completed |
North Florida Foundation for Research and Education |
2017-12-31 |
| NCT02292498 |
Thermal Imaging to Diagnose and Monitor Suspected Bacterial Infections |
https://ClinicalTrials.gov/show/NCT02292498 |
Completed |
Massachusetts General Hospital |
2016-06-30 |
| NCT02285075 |
Temocillin Pharmacokinetic in Hemodialysis |
https://ClinicalTrials.gov/show/NCT02285075 |
Completed |
AZ Sint-Jan AV |
2014-12-31 |
| NCT02269319 |
MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection |
https://ClinicalTrials.gov/show/NCT02269319 |
Completed |
MicuRx |
2015-08-31 |
| NCT02268279 |
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children |
https://ClinicalTrials.gov/show/NCT02268279 |
Completed |
Melinta Therapeutics, Inc. |
2016-10-31 |
| NCT02266706 |
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010) |
https://ClinicalTrials.gov/show/NCT02266706 |
Completed |
Cubist Pharmaceuticals LLC |
2017-06-08 |
| NCT02214433 |
A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02214433 |
Completed |
Debiopharm International SA |
2015-02-28 |
| NCT02162199 |
A Single Dose Study of Debio 1450 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02162199 |
Completed |
Debiopharm International SA |
2014-10-31 |
| NCT02146209 |
Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate. |
https://ClinicalTrials.gov/show/NCT02146209 |
Completed |
Verisfield UK Ltd. Greek Branch |
2014-06-30 |
| NCT02134834 |
A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595 |
https://ClinicalTrials.gov/show/NCT02134834 |
Completed |
Meiji Seika Pharma Co., Ltd. |
2014-08-31 |
| NCT02134301 |
Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections |
https://ClinicalTrials.gov/show/NCT02134301 |
Recruiting |
Melinta Therapeutics, Inc. |
2021-03-31 |
| NCT02092506 |
RCT: Triple vs Sequential vs Concomitant Therapy H Pylori |
https://ClinicalTrials.gov/show/NCT02092506 |
Completed |
Changi General Hospital |
2014-06-30 |
| NCT02079298 |
Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants |
https://ClinicalTrials.gov/show/NCT02079298 |
Completed |
Karolinska Institutet |
2015-09-30 |
| NCT02066402 |
Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) |
https://ClinicalTrials.gov/show/NCT02066402 |
Completed |
Bayer |
2016-03-06 |
| NCT01283581 |
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections |
https://ClinicalTrials.gov/show/NCT01283581 |
Completed |
Melinta Therapeutics, Inc. |
2011-11-30 |
| NCT01271998 |
Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg |
https://ClinicalTrials.gov/show/NCT01271998 |
Completed |
Trius Therapeutics LLC |
2011-01-03 |
| NCT02052388 |
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections |
https://ClinicalTrials.gov/show/NCT02052388 |
Completed |
Innovation Pharmaceuticals, Inc. |
2014-10-31 |
| NCT02045849 |
Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02045849 |
Completed |
GlaxoSmithKline |
2014-08-21 |
| NCT02045797 |
Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections |
https://ClinicalTrials.gov/show/NCT02045797 |
Completed |
GlaxoSmithKline |
2015-06-29 |
| NCT02013141 |
Telavancin Pediatric PK Study (Ages >3 Months to 17 Years) |
https://ClinicalTrials.gov/show/NCT02013141 |
Recruiting |
Cumberland Pharmaceuticals |
2022-12-31 |
| NCT01984684 |
Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections |
https://ClinicalTrials.gov/show/NCT01984684 |
Completed |
Melinta Therapeutics, Inc. |
2015-12-31 |
| NCT01968395 |
Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure |
https://ClinicalTrials.gov/show/NCT01968395 |
Completed |
Erasme University Hospital |
2014-08-31 |
| NCT01966055 |
Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents |
https://ClinicalTrials.gov/show/NCT01966055 |
Completed |
Melinta Therapeutics, Inc. |
2014-08-31 |
| NCT01949103 |
TD-1607 MAD Study in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01949103 |
Completed |
Theravance Biopharma |
2014-06-30 |
| NCT01946568 |
A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years. |
https://ClinicalTrials.gov/show/NCT01946568 |
Completed |
Durata Therapeutics Inc., an affiliate of Allergan plc |
2015-04-30 |
| NCT01934205 |
To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944 |
https://ClinicalTrials.gov/show/NCT01934205 |
Completed |
GlaxoSmithKline |
2013-12-21 |
| NCT01897779 |
Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT01897779 |
Completed |
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) |
2014-02-28 |
| NCT01892358 |
Preventing Bacterial and Viral Infections Among Injection Drug Users |
https://ClinicalTrials.gov/show/NCT01892358 |
Completed |
Butler Hospital |
2019-08-31 |
| NCT01845246 |
Multicentric Study About the Usefulness of Monitoring Plasma Levels of Colistin and Sodium Colistimethate in Patients With Infections Due to Multi-drug Resistant Gram Negative Bacilli, Treated With Colistin |
https://ClinicalTrials.gov/show/NCT01845246 |
Completed |
Parc de Salut Mar |
2015-01-31 |
| NCT01839188 |
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) |
https://ClinicalTrials.gov/show/NCT01839188 |
Completed |
MCM Vaccines B.V. |
2014-03-19 |
| NCT01839175 |
Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination |
https://ClinicalTrials.gov/show/NCT01839175 |
Completed |
Sanofi |
2014-07-31 |
| NCT01817075 |
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01817075 |
Completed |
Children’s Oncology Group |
2019-03-31 |
| NCT01812382 |
Retapamulin Microdialysis Feasibility Study |
https://ClinicalTrials.gov/show/NCT01812382 |
Completed |
GlaxoSmithKline |
2014-05-27 |
| NCT01811732 |
Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections |
https://ClinicalTrials.gov/show/NCT01811732 |
Completed |
Melinta Therapeutics, Inc. |
2014-07-31 |
| NCT01800942 |
Prevention of Bacterial Infections in Newborn |
https://ClinicalTrials.gov/show/NCT01800942 |
Completed |
London School of Hygiene and Tropical Medicine |
2014-12-31 |
| NCT01800396 |
Milk Ingredients and Resistance Against E-coli-induced GastroEnteritis (MIRAGE) |
https://ClinicalTrials.gov/show/NCT01800396 |
Completed |
NIZO Food Research |
2013-05-31 |
| NCT01772836 |
Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination |
https://ClinicalTrials.gov/show/NCT01772836 |
Completed |
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) |
2013-03-31 |
| NCT01751269 |
Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT01751269 |
Completed |
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) |
2013-07-31 |
| NCT01746654 |
Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients |
https://ClinicalTrials.gov/show/NCT01746654 |
Completed |
GangaGen, Inc. |
2015-10-31 |
| NCT01744730 |
Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile |
https://ClinicalTrials.gov/show/NCT01744730 |
Completed |
Duke University |
2014-08-31 |
| NCT01732250 |
Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem |
https://ClinicalTrials.gov/show/NCT01732250 |
Completed |
Rabin Medical Center |
2017-01-31 |
| NCT01709266 |
The Effect of Probiotics on E. Coli-induced Gastroenteritis |
https://ClinicalTrials.gov/show/NCT01709266 |
Completed |
NIZO Food Research |
2012-11-30 |
| NCT01702649 |
Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT01702649 |
Completed |
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) |
2012-11-30 |
| NCT01689207 |
To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) |
https://ClinicalTrials.gov/show/NCT01689207 |
Completed |
Pfizer |
2014-12-31 |
| NCT01663389 |
A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose |
https://ClinicalTrials.gov/show/NCT01663389 |
Completed |
GlaxoSmithKline |
2012-10-05 |
| NCT01648179 |
A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01648179 |
Completed |
GlaxoSmithKline |
2012-05-31 |
| NCT01638702 |
Study of Complication Rates Associated With PICC for Left vs Right |
https://ClinicalTrials.gov/show/NCT01638702 |
Completed |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2015-09-30 |
| NCT01623154 |
POCone-UBiT-IR300 Pediatric Comparison Study |
https://ClinicalTrials.gov/show/NCT01623154 |
Completed |
Otsuka America Pharmaceutical |
2013-03-31 |
| NCT01610388 |
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01610388 |
Completed |
GlaxoSmithKline |
2012-01-26 |
| NCT01608815 |
Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects |
https://ClinicalTrials.gov/show/NCT01608815 |
Completed |
Sanofi |
2012-09-30 |
| NCT01587937 |
Hospital Wide Roll-Out of Antimicrobial Stewardship |
https://ClinicalTrials.gov/show/NCT01587937 |
Completed |
Sunnybrook Health Sciences Centre |
2012-04-30 |
| NCT01586169 |
Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination |
https://ClinicalTrials.gov/show/NCT01586169 |
Completed |
Centre d’Appui à la lutte contre la Maladie |
2010-02-28 |
| NCT01553279 |
Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) |
https://ClinicalTrials.gov/show/NCT01553279 |
Completed |
MCM Vaccines B.V. |
2013-09-27 |
| NCT01528969 |
Effect of Xylitol on Oral Microbiota in Children |
https://ClinicalTrials.gov/show/NCT01528969 |
Completed |
Kuwait University |
2012-04-30 |
| NCT01519492 |
A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci |
https://ClinicalTrials.gov/show/NCT01519492 |
Completed |
Affinium Pharmaceuticals, Ltd |
2012-08-31 |
| NCT01506986 |
Helicobacter Eradication Aspirin Trial |
https://ClinicalTrials.gov/show/NCT01506986 |
Active, not recruiting |
University of Nottingham |
2017-10-31 |
| NCT01485705 |
Retrospective Examination of Initial Care of Severe Bacterial Infections of the Child |
https://ClinicalTrials.gov/show/NCT01485705 |
Completed |
Nantes University Hospital |
2014-01-31 |
| NCT01480258 |
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) |
https://ClinicalTrials.gov/show/NCT01480258 |
Completed |
MCM Vaccines B.V. |
2013-10-09 |
| NCT01446289 |
Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings |
https://ClinicalTrials.gov/show/NCT01446289 |
Completed |
Novartis |
2013-04-30 |
| NCT01431989 |
Amoxicillin Bioequivalence Study Brazil - Fast |
https://ClinicalTrials.gov/show/NCT01431989 |
Completed |
GlaxoSmithKline |
2011-06-11 |
| NCT01421511 |
TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections |
https://ClinicalTrials.gov/show/NCT01421511 |
Completed |
Trius Therapeutics LLC |
2013-01-10 |
| NCT01412801 |
Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings |
https://ClinicalTrials.gov/show/NCT01412801 |
Completed |
Novartis |
2012-10-31 |
| NCT01402713 |
To Evaluate the Effectiveness(Immunogenicity) and Safety of ‘GC1107’ Administered Intramuscularly in Healthy Children |
https://ClinicalTrials.gov/show/NCT01402713 |
Completed |
Green Cross Corporation |
2013-11-30 |
| NCT01381848 |
A Study of Doripenem in Infants Less Than 12 Weeks of Age |
https://ClinicalTrials.gov/show/NCT01381848 |
Completed |
Janssen Research & Development, LLC |
2012-04-30 |
| NCT01371656 |
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01371656 |
Completed |
Children’s Oncology Group |
2017-06-30 |
| NCT01341639 |
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) |
https://ClinicalTrials.gov/show/NCT01341639 |
Completed |
MCM Vaccines B.V. |
2013-03-13 |
| NCT01340937 |
A Study of V419 Given Concomitantly With Prevnar 13â„¢ and RotaTeqâ„¢ (V419-006) |
https://ClinicalTrials.gov/show/NCT01340937 |
Completed |
Merck Sharp & Dohme Corp. |
2012-12-18 |
| NCT01337167 |
Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13â„¢ and RotaTeqâ„¢ (V419-005) |
https://ClinicalTrials.gov/show/NCT01337167 |
Completed |
Merck Sharp & Dohme Corp. |
2013-05-09 |
| NCT00353158 |
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity |
https://ClinicalTrials.gov/show/NCT00353158 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-09-20 |
| NCT04404855 |
Antibiotic Selection Using Next Generation Sequencing vs Urine Culture |
https://ClinicalTrials.gov/show/NCT04404855 |
Recruiting |
The University of Texas Health Science Center at San Antonio |
2022-12-31 |
| NCT04297176 |
Economic Evaluation of Vancomycin Therapeutic Drug Monitoring Methods |
https://ClinicalTrials.gov/show/NCT04297176 |
Active, not recruiting |
Hamad Medical Corporation |
2020-07-30 |
| NCT04291768 |
Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia |
https://ClinicalTrials.gov/show/NCT04291768 |
Recruiting |
Hvidovre University Hospital |
2023-10-01 |
| NCT04263792 |
[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects |
https://ClinicalTrials.gov/show/NCT04263792 |
Recruiting |
University of Pennsylvania |
2021-01-31 |
| NCT04215991 |
Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients |
https://ClinicalTrials.gov/show/NCT04215991 |
Recruiting |
Shionogi Inc. |
2023-03-15 |
| NCT04100772 |
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above |
https://ClinicalTrials.gov/show/NCT04100772 |
Recruiting |
CanSino Biologics Inc. |
2020-10-01 |
| NCT04079790 |
Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects |
https://ClinicalTrials.gov/show/NCT04079790 |
Completed |
GlaxoSmithKline |
2019-11-25 |
| NCT04070469 |
Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment (MAX-AMOX) |
https://ClinicalTrials.gov/show/NCT04070469 |
Recruiting |
University Hospital, Clermont-Ferrand |
2021-12-31 |
| NCT04067531 |
Treatment of BV With First Deqularum and Then Direkt After Clindamycin |
https://ClinicalTrials.gov/show/NCT04067531 |
Recruiting |
Skaraborg Hospital |
2020-08-01 |
| NCT04020341 |
A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI) |
https://ClinicalTrials.gov/show/NCT04020341 |
Recruiting |
GlaxoSmithKline |
2021-04-28 |
| NCT04011657 |
Effective Antimicrobial StewaRdship StrategIES (ARIES) |
https://ClinicalTrials.gov/show/NCT04011657 |
Completed |
Tan Tock Seng Hospital |
2017-09-30 |
| NCT04005560 |
Patient’s Quality of Life Assessment 5 to 10 Years After Hospitalization in Intensive Care Unit for a Severe Bacterial Infection |
https://ClinicalTrials.gov/show/NCT04005560 |
Recruiting |
Nantes University Hospital |
2020-07-26 |
| NCT03998865 |
Bacterial Microbiota Characterization on Implant-supported PEEK and Titanium Provisional Abutments |
https://ClinicalTrials.gov/show/NCT03998865 |
Completed |
University of Concepcion, Chile |
2019-12-11 |
| NCT03969901 |
Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021) |
https://ClinicalTrials.gov/show/NCT03969901 |
Recruiting |
Merck Sharp & Dohme Corp. |
2022-11-13 |
| NCT03964493 |
TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection |
https://ClinicalTrials.gov/show/NCT03964493 |
Recruiting |
TenNor Therapeutics Limited |
2019-09-18 |
| NCT03941951 |
Study to Optimize the Use of New Antibiotics |
https://ClinicalTrials.gov/show/NCT03941951 |
Recruiting |
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla |
2020-12-31 |
| NCT03939429 |
Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT03939429 |
Completed |
Qpex Biopharma, Inc. |
2019-10-06 |
| NCT03903783 |
Impact of Cefotaxime and Ceftriaxone on the Emergence and Carrying of Multidrug-Resistant Bacteria |
https://ClinicalTrials.gov/show/NCT03903783 |
Active, not recruiting |
Groupe Hospitalier Paris Saint Joseph |
2020-01-06 |
| NCT03816956 |
Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301 |
https://ClinicalTrials.gov/show/NCT03816956 |
Recruiting |
Aridis Pharmaceuticals, Inc. |
2020-08-31 |
| NCT03774940 |
Blood Parameters as a Predictor of Fever After Percutaneous Nephrolithotomy |
https://ClinicalTrials.gov/show/NCT03774940 |
Completed |
TC Erciyes University |
2013-12-01 |
| NCT03761043 |
Nurse Promotion of IV to PO Antimicrobial Conversion |
https://ClinicalTrials.gov/show/NCT03761043 |
Completed |
Kelowna General Hospital |
2019-04-07 |
| NCT03752424 |
Topical Silver Nanoparticles for Microbial Activity |
https://ClinicalTrials.gov/show/NCT03752424 |
Recruiting |
Al-Azhar University |
2020-01-12 |
| NCT03747497 |
Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection |
https://ClinicalTrials.gov/show/NCT03747497 |
Recruiting |
MicuRx |
2019-05-30 |
| NCT03696550 |
A Safety and PK Study of IV Eravacycline |
https://ClinicalTrials.gov/show/NCT03696550 |
Recruiting |
Tetraphase Pharmaceuticals, Inc. |
2020-08-27 |
| NCT03688321 |
Probiotic on Prevention of GBS Vaginal Infection During Pregnancy |
https://ClinicalTrials.gov/show/NCT03688321 |
Recruiting |
China Medical University Hospital |
2019-07-31 |
| NCT03671967 |
PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) |
https://ClinicalTrials.gov/show/NCT03671967 |
Recruiting |
Rambam Health Care Campus |
2024-01-31 |
| NCT03667937 |
Effectiveness of a Hydrophobic Dressing for Microorganisms’ Colonization and Infection Control of Vascular Ulcers |
https://ClinicalTrials.gov/show/NCT03667937 |
Recruiting |
University of Malaga |
2020-12-30 |
| NCT03633188 |
Stool Biobanking and Impact of Antimicrobials on the Gut Microbiota in Patients With Bone and Joint Infection |
https://ClinicalTrials.gov/show/NCT03633188 |
Recruiting |
Hospices Civils de Lyon |
2022-07-31 |
| NCT03590600 |
A Single Ascending Dose Study of BTZ043 |
https://ClinicalTrials.gov/show/NCT03590600 |
Completed |
Ludwig-Maximilians - University of Munich |
2018-08-14 |
| NCT03562117 |
Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function |
https://ClinicalTrials.gov/show/NCT03562117 |
Completed |
GlaxoSmithKline |
2018-12-26 |
| NCT03450187 |
A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study |
https://ClinicalTrials.gov/show/NCT03450187 |
Completed |
Tetraphase Pharmaceuticals, Inc. |
2018-12-31 |
| NCT03440216 |
Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units |
https://ClinicalTrials.gov/show/NCT03440216 |
Recruiting |
Université Catholique de Louvain |
2019-10-15 |
| NCT03424525 |
11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects |
https://ClinicalTrials.gov/show/NCT03424525 |
Recruiting |
University of Pennsylvania |
2020-11-30 |
| NCT01262885 |
A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT01262885 |
Completed |
GlaxoSmithKline |
2011-08-25 |
| NCT01244698 |
Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction |
https://ClinicalTrials.gov/show/NCT01244698 |
Completed |
Stony Brook University |
2014-05-31 |
| NCT01225042 |
The Effect of Probiotics on E. Coli Gastroenteritis |
https://ClinicalTrials.gov/show/NCT01225042 |
Completed |
NIZO Food Research |
2010-12-31 |
| NCT01209078 |
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection |
https://ClinicalTrials.gov/show/NCT01209078 |
Completed |
GlaxoSmithKline |
2011-01-18 |
| NCT01170221 |
TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections. |
https://ClinicalTrials.gov/show/NCT01170221 |
Completed |
Trius Therapeutics LLC |
2011-09-30 |
| NCT01156077 |
Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients |
https://ClinicalTrials.gov/show/NCT01156077 |
Completed |
Trius Therapeutics LLC |
2011-09-24 |
| NCT01119105 |
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) |
https://ClinicalTrials.gov/show/NCT01119105 |
Completed |
Nabriva Therapeutics AG |
2010-12-31 |
| NCT01111864 |
Changes in Microbiota and Iron Status After Iron Fortification of Complementary Foods |
https://ClinicalTrials.gov/show/NCT01111864 |
Completed |
Swiss Federal Institute of Technology |
2012-09-30 |
| NCT01074775 |
Human Innate Immune Responses To Mycobacterial Aerodigestive Tract Infection |
https://ClinicalTrials.gov/show/NCT01074775 |
Completed |
St George’s, University of London |
2007-09-30 |
| NCT01059890 |
Cerebral Antibiotics Distribution After Acute Brain Injury |
https://ClinicalTrials.gov/show/NCT01059890 |
Completed |
Poitiers University Hospital |
2013-06-30 |
| NCT01058824 |
Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule |
https://ClinicalTrials.gov/show/NCT01058824 |
Completed |
Pfizer |
2009-04-30 |
| NCT01019395 |
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics |
https://ClinicalTrials.gov/show/NCT01019395 |
Completed |
Cubist Pharmaceuticals LLC |
2012-03-20 |
| NCT01018641 |
An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults |
https://ClinicalTrials.gov/show/NCT01018641 |
Completed |
Pfizer |
2011-01-31 |
| NCT01015014 |
Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections |
https://ClinicalTrials.gov/show/NCT01015014 |
Completed |
Pfizer |
2010-05-13 |
| NCT01012089 |
Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease |
https://ClinicalTrials.gov/show/NCT01012089 |
Completed |
University of Oklahoma |
2014-04-30 |
| NCT00983255 |
Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA) |
https://ClinicalTrials.gov/show/NCT00983255 |
Completed |
Trius Therapeutics LLC |
2010-01-31 |
| NCT00965848 |
A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections |
https://ClinicalTrials.gov/show/NCT00965848 |
Completed |
Janssen-Cilag Ltd.,Thailand |
2010-07-31 |
| NCT00945152 |
Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM) |
https://ClinicalTrials.gov/show/NCT00945152 |
Recruiting |
Robert S Berman MD |
2020-12-31 |
| NCT00939562 |
Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate |
https://ClinicalTrials.gov/show/NCT00939562 |
Completed |
Pfizer |
2008-12-31 |
| NCT00924911 |
Relative Bioavailability Study in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT00924911 |
Completed |
GlaxoSmithKline |
2009-07-09 |
| NCT00896558 |
A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT00896558 |
Completed |
GlaxoSmithKline |
2009-09-25 |
| NCT00852540 |
Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA |
https://ClinicalTrials.gov/show/NCT00852540 |
Completed |
GlaxoSmithKline |
2010-07-31 |
| NCT04328051 |
Influence of the Implant-prosthetic Connection in the Marginal Bone Loss and Bacterial Leakage |
https://ClinicalTrials.gov/show/NCT04328051 |
Recruiting |
University of Barcelona |
2021-06-13 |
| NCT01252199 |
Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2 |
https://ClinicalTrials.gov/show/NCT01252199 |
Completed |
Thallion Pharmaceuticals |
2012-12-31 |
| NCT00828867 |
Single Dose Escalation First Time in Human PK Study |
https://ClinicalTrials.gov/show/NCT00828867 |
Completed |
GlaxoSmithKline |
2009-12-07 |
| NCT03397914 |
Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections |
https://ClinicalTrials.gov/show/NCT03397914 |
Recruiting |
National Cancer Institute, Egypt |
2019-05-31 |
| NCT04126031 |
Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants. |
https://ClinicalTrials.gov/show/NCT04126031 |
Recruiting |
Pfizer |
2021-12-18 |
| NCT03925480 |
Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial |
https://ClinicalTrials.gov/show/NCT03925480 |
Recruiting |
Murdoch Childrens Research Institute |
2021-08-31 |
| NCT03332732 |
VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT03332732 |
Completed |
VenatoRx Pharmaceuticals, Inc. |
2017-12-20 |
| NCT02426918 |
Study of Debio 1450 for Bacterial Skin Infections |
https://ClinicalTrials.gov/show/NCT02426918 |
Completed |
Debiopharm International SA |
2016-08-31 |
| NCT02572791 |
Staph Household Intervention for Eradication (SHINE) |
https://ClinicalTrials.gov/show/NCT02572791 |
Recruiting |
Washington University School of Medicine |
2021-08-31 |
| NCT03801213 |
Evaluation of Urine Samples Obtained by Bladder Stimulation for the Diagnosis of Urinary Tract Infection in Infants |
https://ClinicalTrials.gov/show/NCT03801213 |
Recruiting |
Fondation Lenval |
2020-12-31 |
| NCT00760279 |
An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates |
https://ClinicalTrials.gov/show/NCT00760279 |
Completed |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
NA |
| NCT00723502 |
Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients |
https://ClinicalTrials.gov/show/NCT00723502 |
Completed |
MerLion Pharmaceuticals GmbH |
2009-04-30 |
| NCT00692848 |
Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source |
https://ClinicalTrials.gov/show/NCT00692848 |
Completed |
St. Justine’s Hospital |
2007-11-30 |
| NCT00684177 |
Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL) |
https://ClinicalTrials.gov/show/NCT00684177 |
Completed |
GlaxoSmithKline |
2009-10-31 |
| NCT00678106 |
Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections |
https://ClinicalTrials.gov/show/NCT00678106 |
Completed |
Pfizer |
2009-07-31 |
| NCT00670215 |
BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis |
https://ClinicalTrials.gov/show/NCT00670215 |
Completed |
Bayer |
NA |
| NCT00668044 |
Ciprofloxacin on Burned Patients |
https://ClinicalTrials.gov/show/NCT00668044 |
Completed |
Bayer |
2003-11-30 |
| NCT00633152 |
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections |
https://ClinicalTrials.gov/show/NCT00633152 |
Completed |
Forest Laboratories |
2008-07-31 |
| NCT00629382 |
Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis |
https://ClinicalTrials.gov/show/NCT00629382 |
Completed |
St. Bortolo Hospital |
2008-04-30 |
| NCT00575380 |
Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery |
https://ClinicalTrials.gov/show/NCT00575380 |
Completed |
Merck Sharp & Dohme Corp. |
2008-06-30 |
| NCT00575367 |
Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00575367 |
Completed |
Merck Sharp & Dohme Corp. |
2008-10-31 |
| NCT00564447 |
Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00564447 |
Completed |
Merck Sharp & Dohme Corp. |
2007-12-31 |
| NCT00555061 |
Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. |
https://ClinicalTrials.gov/show/NCT00555061 |
Completed |
GlaxoSmithKline |
2008-08-31 |
| NCT00551915 |
A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003) |
https://ClinicalTrials.gov/show/NCT00551915 |
Completed |
Merck Sharp & Dohme Corp. |
2003-01-31 |
| NCT00551629 |
A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002) |
https://ClinicalTrials.gov/show/NCT00551629 |
Completed |
Merck Sharp & Dohme Corp. |
2003-03-31 |
| NCT00539994 |
Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus |
https://ClinicalTrials.gov/show/NCT00539994 |
Completed |
GlaxoSmithKline |
2008-01-31 |
| NCT00517673 |
To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects |
https://ClinicalTrials.gov/show/NCT00517673 |
Completed |
GlaxoSmithKline |
2008-09-30 |
| NCT00515151 |
Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride |
https://ClinicalTrials.gov/show/NCT00515151 |
Completed |
University Hospital Freiburg |
NA |
| NCT00515034 |
A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia |
https://ClinicalTrials.gov/show/NCT00515034 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2008-11-30 |
| NCT00509938 |
Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients |
https://ClinicalTrials.gov/show/NCT00509938 |
Completed |
AM-Pharma |
2006-11-30 |
| NCT00501150 |
Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections |
https://ClinicalTrials.gov/show/NCT00501150 |
Completed |
Imperial College London |
NA |
| NCT00493922 |
Trial of Rapid Diagnostic Tests in Rural Ghana |
https://ClinicalTrials.gov/show/NCT00493922 |
Completed |
London School of Hygiene and Tropical Medicine |
2008-12-31 |
| NCT00490477 |
The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT00490477 |
Completed |
University of Turin, Italy |
2007-07-31 |
| NCT00488345 |
Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age |
https://ClinicalTrials.gov/show/NCT00488345 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2009-09-30 |
| NCT00488189 |
Study Evaluation Tazocin Intervention |
https://ClinicalTrials.gov/show/NCT00488189 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2008-02-29 |
| NCT00478855 |
Tazocin Intervention Study |
https://ClinicalTrials.gov/show/NCT00478855 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00472667 |
PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA) |
https://ClinicalTrials.gov/show/NCT00472667 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2008-05-31 |
| NCT00431483 |
Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards |
https://ClinicalTrials.gov/show/NCT00431483 |
Completed |
Ludwig-Maximilians - University of Munich |
2008-02-29 |
| NCT00427141 |
A Three-Part Study Of GSK580416 In Healthy Subjects |
https://ClinicalTrials.gov/show/NCT00427141 |
Completed |
GlaxoSmithKline |
NA |
| NCT00424190 |
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections |
https://ClinicalTrials.gov/show/NCT00424190 |
Completed |
Forest Laboratories |
2007-11-30 |
| NCT00423657 |
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections |
https://ClinicalTrials.gov/show/NCT00423657 |
Completed |
Forest Laboratories |
2007-12-31 |
| NCT00410527 |
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients |
https://ClinicalTrials.gov/show/NCT00410527 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00406198 |
Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis |
https://ClinicalTrials.gov/show/NCT00406198 |
Completed |
Hopital Lariboisière |
NA |
| NCT00389558 |
Antiseptic Use and Dressing Application |
https://ClinicalTrials.gov/show/NCT00389558 |
Completed |
Maternite Regionale Universitaire |
2008-09-30 |
| NCT00366249 |
Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis. |
https://ClinicalTrials.gov/show/NCT00366249 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2009-03-31 |
| NCT00358371 |
Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg) |
https://ClinicalTrials.gov/show/NCT00358371 |
Completed |
GlaxoSmithKline |
2005-02-08 |
| NCT00357539 |
Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00357539 |
Completed |
Laboratoires Thea |
NA |
| NCT00357383 |
Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00357383 |
Completed |
Laboratoires Thea |
NA |
| NCT00357292 |
Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00357292 |
Completed |
Laboratoires Thea |
NA |
| NCT00356850 |
Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00356850 |
Completed |
Laboratoires Thea |
NA |
| NCT00356772 |
Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00356772 |
Completed |
Laboratoires Thea |
NA |
| NCT00347386 |
Therapeutic Zinc in Infant Bacterial Illness |
https://ClinicalTrials.gov/show/NCT00347386 |
Completed |
Centre For International Health |
2008-12-31 |
| NCT00324168 |
Steroids for Corneal Ulcers Trial |
https://ClinicalTrials.gov/show/NCT00324168 |
Completed |
University of California, San Francisco |
2011-02-28 |
| NCT00318344 |
Evaluation of Atuna Racemosa Toxicity |
https://ClinicalTrials.gov/show/NCT00318344 |
Completed |
Mayo Clinic |
2007-11-30 |
| NCT00288418 |
Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization |
https://ClinicalTrials.gov/show/NCT00288418 |
Completed |
Angiotech Pharmaceuticals |
2007-07-31 |
| NCT00271440 |
Effect of Chlorhexidine Cleansing on Skin Flora of Newborns in Nepal |
https://ClinicalTrials.gov/show/NCT00271440 |
Completed |
Johns Hopkins Bloomberg School of Public Health |
2006-04-30 |
| NCT00258102 |
A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections |
https://ClinicalTrials.gov/show/NCT00258102 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00254696 |
Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs) |
https://ClinicalTrials.gov/show/NCT00254696 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-03-31 |
| NCT00229060 |
Doripenem in the Treatment of Complicated Intra-Abdominal Infections |
https://ClinicalTrials.gov/show/NCT00229060 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00216450 |
Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults. |
https://ClinicalTrials.gov/show/NCT00216450 |
Completed |
Janssen Cilag Pharmaceutica S.A.C.I., Greece |
NA |
| NCT00210938 |
Doripenem in the Treatment of Complicated Intra-Abdominal Infections |
https://ClinicalTrials.gov/show/NCT00210938 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00205816 |
Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens. |
https://ClinicalTrials.gov/show/NCT00205816 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-11-30 |
| NCT00200928 |
Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood. |
https://ClinicalTrials.gov/show/NCT00200928 |
Completed |
The Netherlands Asthma Foundation |
NA |
| NCT00198627 |
Etiology, Prevention and Treatment of Neonatal Infections in the Community |
https://ClinicalTrials.gov/show/NCT00198627 |
Completed |
Johns Hopkins Bloomberg School of Public Health |
2007-09-30 |
| NCT00176124 |
Leukocyte Depletion of Autologous Whole Blood |
https://ClinicalTrials.gov/show/NCT00176124 |
Completed |
Heidelberg University |
2005-04-30 |
| NCT00170586 |
Novel Protective Underglove |
https://ClinicalTrials.gov/show/NCT00170586 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00170430 |
Reducing Vaginal Infections in Women |
https://ClinicalTrials.gov/show/NCT00170430 |
Completed |
University of Washington |
2006-12-31 |
| NCT00147511 |
Time To Efficacy and Onset Of Action Of Linezolid |
https://ClinicalTrials.gov/show/NCT00147511 |
Completed |
Pfizer |
NA |
| NCT00136292 |
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics |
https://ClinicalTrials.gov/show/NCT00136292 |
Completed |
Cubist Pharmaceuticals LLC |
2006-08-01 |
| NCT00133874 |
Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo |
https://ClinicalTrials.gov/show/NCT00133874 |
Completed |
GlaxoSmithKline |
2005-09-30 |
| NCT00100386 |
Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial |
https://ClinicalTrials.gov/show/NCT00100386 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00100308 |
Unfractioned Heparin for Treatment of Sepsis |
https://ClinicalTrials.gov/show/NCT00100308 |
Completed |
Universidad de Antioquia |
2007-07-31 |
| NCT00081744 |
Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects |
https://ClinicalTrials.gov/show/NCT00081744 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2004-08-31 |
| NCT00079989 |
Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms |
https://ClinicalTrials.gov/show/NCT00079989 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-11-30 |
| NCT00079976 |
Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA) |
https://ClinicalTrials.gov/show/NCT00079976 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-06-30 |
| NCT00062647 |
Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia |
https://ClinicalTrials.gov/show/NCT00062647 |
Completed |
Cumberland Pharmaceuticals |
2006-08-31 |
| NCT00044928 |
Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection |
https://ClinicalTrials.gov/show/NCT00044928 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2004-02-29 |
| NCT00795145 |
A Study To Assess The Effect Of Linezolid On QTc Interval |
https://ClinicalTrials.gov/show/NCT00795145 |
Completed |
Pfizer |
2009-03-31 |
| NCT00037050 |
Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria |
https://ClinicalTrials.gov/show/NCT00037050 |
Completed |
Pfizer |
NA |
| NCT00035854 |
New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) |
https://ClinicalTrials.gov/show/NCT00035854 |
Completed |
Pfizer |
NA |
| NCT00008853 |
Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines |
https://ClinicalTrials.gov/show/NCT00008853 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00002344 |
A Study of Azithromycin in HIV-Infected Patients |
https://ClinicalTrials.gov/show/NCT00002344 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002139 |
Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects. |
https://ClinicalTrials.gov/show/NCT00002139 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00000826 |
Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites |
https://ClinicalTrials.gov/show/NCT00000826 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000811 |
A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children |
https://ClinicalTrials.gov/show/NCT00000811 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00035269 |
New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia) |
https://ClinicalTrials.gov/show/NCT00035269 |
Completed |
Pfizer |
NA |
| NCT00004829 |
Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00004829 |
Completed |
FDA Office of Orphan Products Development |
NA |
| NCT00004747 |
Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00004747 |
Completed |
Office of Rare Diseases (ORD) |
NA |